Ankylosing Spondylitis Center

Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.

The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.

The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.

The US Food and Drug Administration has approved its fourth biosimilar.

The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept. 

The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.

Clinicians are generally familiar with the side effects of most prescribed medications. However, the safety of newer medications such as golimumab, an anti-TNF drug to treat autoimmune disorders, is still being examined.

Many people are living with more than one chronic disease. According to a recent study, many newly diagnosed arthritis patients may be living with another chronic disease.

There are many reasons to quit smoking, and people with ankylosing spondylitis can add another to the list.

New options developed this week for patients coping with two very different arthritic conditions. T he US  Food and Drug Administration (FDA) has approved two medications for treatment of both rheumatoid arthritis and ankylosing spondylitis.

If you were diagnosed with ankylosing spondylitis, your doctor may have recommended that you watch your posture and exercise regularly. But have you followed these instructions in the same way you would your prescribed medication? Well, new findings may convince you to workout more.

Exercise is a key part of managing arthritis of the spine. But exercise comes in many forms. So, for patients with spinal arthritis, what are the benefits of different types of exercise?

Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.

Many diseases are driven by inflammation, or the swelling of tissues and organs. Inflammation plays a part in both arthritis and gum disease. As such, there may be a link between arthritis and gum disease.

Inflammation is the reason patients with rheumatoid arthritis develop swollen and painful joints. But inflammation is not unique to rheumatoid arthritis; it is also behind other painful joint conditions.

Patients with ankylosing spondylitis have a number of drugs to choose from. When a new drug comes along, it must go through strict testing to see if it is safe and effective.

A long term disease named  Ankylosing   Spondylitis has been linked to a higher risk of cardiovascular problems. A number of factors could be responsible for this increased risk, including the drugs used to treat this painful condition.

Ankylosing spondylitis on its own is enough to keep patients from living a normal, active life. Add obesity to the mix and the picture may get worse.

No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.

Chronic pain can make it hard to do your job or to even get a job. Drugs may aid some chronic pain patients with their work troubles. But when it comes to ankylosing spondylitis , it's still unclear if certain drugs help.